Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

(Reuters) – Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to speed development of cancer medicines and support its efforts to price them based on how well they work.

Powered by WPeMatico

Scroll to top